Loading…
NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases
Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases...
Saved in:
Published in: | Frontiers in immunology 2017-04, Vol.8, p.399-399 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3 |
---|---|
cites | cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3 |
container_end_page | 399 |
container_issue | |
container_start_page | 399 |
container_title | Frontiers in immunology |
container_volume | 8 |
creator | Aksentijevich, Ivona Zhou, Qing |
description | Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation. |
doi_str_mv | 10.3389/fimmu.2017.00399 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085</doaj_id><sourcerecordid>1895275210</sourcerecordid><originalsourceid>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</originalsourceid><addsrcrecordid>eNp1ks1O3DAUhaOqVUGUfVeVl91k8E_sxF1UojOlRaKURVlbjn09GCUxxA4o79Gn4SH6TPXMUASLemFb597zXUs-RfGe4AVjjTxyvu-nBcWkXmDMpHxV7BMhqpJRWr1-dt8rDmO8xnlVkjHG3xZ7tKmEFBTvF7_PT8o_D1_QhU5X93pGfkDHUwp-cJ3ue53COKOVj6AjxE9oNccR1lOnkw8DCg5djCFB9vwI1jtvtnpE7YwuW387-ZRLK3B-gIg0Ood7tNQJ1htoNv930LvijdNdhMPH86C4PPn6a_m9PPv57XR5fFaaStBUEuew0U42stGVpdhIaDGpTN4Bg-GOWMpqEA1voNZOO6pb5irAPPc0lWUHxemOa4O-Vjej7_U4q6C92gphXCs9Jm86UIZwyWsrBBG2sty0jtY2a7V1WOCGZ9bnHetmanuwBoY06u4F9GVl8FdqHe4UZ5ILuQF8fASM4XaCmFTvo4Gu0wOEKSrSSE5rTgnOrXjXasYQ84-4pzEEq0021DYbapMNtc1Gtnx4_rwnw78ksL-rWrsl</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1895275210</pqid></control><display><type>article</type><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><source>PubMed Central</source><creator>Aksentijevich, Ivona ; Zhou, Qing</creator><creatorcontrib>Aksentijevich, Ivona ; Zhou, Qing</creatorcontrib><description>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</description><identifier>ISSN: 1664-3224</identifier><identifier>EISSN: 1664-3224</identifier><identifier>DOI: 10.3389/fimmu.2017.00399</identifier><identifier>PMID: 28469620</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>haploinsufficiency of A20 ; Immunology ; linear ubiquitin chain assembly complex ; LUBAC deficiency ; OTULIN ; otulipenia/otulin-related autoinflammatory syndrome ; TNFAIP3/A20</subject><ispartof>Frontiers in immunology, 2017-04, Vol.8, p.399-399</ispartof><rights>Copyright © 2017 Aksentijevich and Zhou. 2017 Aksentijevich and Zhou</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</citedby><cites>FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395695/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC5395695/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28469620$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Aksentijevich, Ivona</creatorcontrib><creatorcontrib>Zhou, Qing</creatorcontrib><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><title>Frontiers in immunology</title><addtitle>Front Immunol</addtitle><description>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</description><subject>haploinsufficiency of A20</subject><subject>Immunology</subject><subject>linear ubiquitin chain assembly complex</subject><subject>LUBAC deficiency</subject><subject>OTULIN</subject><subject>otulipenia/otulin-related autoinflammatory syndrome</subject><subject>TNFAIP3/A20</subject><issn>1664-3224</issn><issn>1664-3224</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><sourceid>DOA</sourceid><recordid>eNp1ks1O3DAUhaOqVUGUfVeVl91k8E_sxF1UojOlRaKURVlbjn09GCUxxA4o79Gn4SH6TPXMUASLemFb597zXUs-RfGe4AVjjTxyvu-nBcWkXmDMpHxV7BMhqpJRWr1-dt8rDmO8xnlVkjHG3xZ7tKmEFBTvF7_PT8o_D1_QhU5X93pGfkDHUwp-cJ3ue53COKOVj6AjxE9oNccR1lOnkw8DCg5djCFB9vwI1jtvtnpE7YwuW387-ZRLK3B-gIg0Ood7tNQJ1htoNv930LvijdNdhMPH86C4PPn6a_m9PPv57XR5fFaaStBUEuew0U42stGVpdhIaDGpTN4Bg-GOWMpqEA1voNZOO6pb5irAPPc0lWUHxemOa4O-Vjej7_U4q6C92gphXCs9Jm86UIZwyWsrBBG2sty0jtY2a7V1WOCGZ9bnHetmanuwBoY06u4F9GVl8FdqHe4UZ5ILuQF8fASM4XaCmFTvo4Gu0wOEKSrSSE5rTgnOrXjXasYQ84-4pzEEq0021DYbapMNtc1Gtnx4_rwnw78ksL-rWrsl</recordid><startdate>20170419</startdate><enddate>20170419</enddate><creator>Aksentijevich, Ivona</creator><creator>Zhou, Qing</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope></search><sort><creationdate>20170419</creationdate><title>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</title><author>Aksentijevich, Ivona ; Zhou, Qing</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>haploinsufficiency of A20</topic><topic>Immunology</topic><topic>linear ubiquitin chain assembly complex</topic><topic>LUBAC deficiency</topic><topic>OTULIN</topic><topic>otulipenia/otulin-related autoinflammatory syndrome</topic><topic>TNFAIP3/A20</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Aksentijevich, Ivona</creatorcontrib><creatorcontrib>Zhou, Qing</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>Frontiers in immunology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Aksentijevich, Ivona</au><au>Zhou, Qing</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases</atitle><jtitle>Frontiers in immunology</jtitle><addtitle>Front Immunol</addtitle><date>2017-04-19</date><risdate>2017</risdate><volume>8</volume><spage>399</spage><epage>399</epage><pages>399-399</pages><issn>1664-3224</issn><eissn>1664-3224</eissn><abstract>Autoinflammatory diseases are caused by defects in genes that regulate the innate immunity. Recently, the scope of autoinflammation has been broadened to include diseases that result from dysregulations in protein modifications by the highly conserved ubiquitin (Ub) peptides. Thus far these diseases consist of linear ubiquitin chain assembly complex (LUBAC) and OTULIN deficiencies, and haploinsufficiency of A20. The LUBAC is critical for linear ubiquitination of key signaling molecules in immune response pathways, while deubiquitinase enzymes, OTULIN and TNFAIP3/A20, reverse the effects of ubiquitination by hydrolyzing linear (Met1) and Lys63 (K63) Ub moieties, respectively, from conjugated proteins. Consequently, OTULIN or A20-deficient cells have an excess of Met1 or K63 Ub chains on NEMO, RIPK1, and other target substrates, which lead to constitutive activation of the NF-kB pathway. Mutant cells produce elevated levels of many proinflammatory cytokines and respond to therapy with cytokine inhibitors. Patients with an impairment in LUBAC stability have compromised NF-kB responses in non-immune cells such as fibroblasts, while their monocytes are hyperresponsive to IL-1β. Discoveries of germline mutations in enzymes that regulate protein modifications by Ub define a new category of autoinflammatory diseases caused by upregulations in the NF-kB signaling. The primary aim of this review is to summarize the latest developments in our understanding of the etiology of autoinflammation.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>28469620</pmid><doi>10.3389/fimmu.2017.00399</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1664-3224 |
ispartof | Frontiers in immunology, 2017-04, Vol.8, p.399-399 |
issn | 1664-3224 1664-3224 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_c15957d6616d4d5cbf27d1597df06085 |
source | PubMed Central |
subjects | haploinsufficiency of A20 Immunology linear ubiquitin chain assembly complex LUBAC deficiency OTULIN otulipenia/otulin-related autoinflammatory syndrome TNFAIP3/A20 |
title | NF-κB Pathway in Autoinflammatory Diseases: Dysregulation of Protein Modifications by Ubiquitin Defines a New Category of Autoinflammatory Diseases |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-01T00%3A35%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=NF-%CE%BAB%20Pathway%20in%20Autoinflammatory%20Diseases:%20Dysregulation%20of%20Protein%20Modifications%20by%20Ubiquitin%20Defines%20a%20New%20Category%20of%20Autoinflammatory%20Diseases&rft.jtitle=Frontiers%20in%20immunology&rft.au=Aksentijevich,%20Ivona&rft.date=2017-04-19&rft.volume=8&rft.spage=399&rft.epage=399&rft.pages=399-399&rft.issn=1664-3224&rft.eissn=1664-3224&rft_id=info:doi/10.3389/fimmu.2017.00399&rft_dat=%3Cproquest_doaj_%3E1895275210%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c462t-1ff0caf9898a4d20c9eb014ceb0e0ec5f1d237e6858e7afaf2ab3f4e054ce84d3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1895275210&rft_id=info:pmid/28469620&rfr_iscdi=true |